Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,316 public trials 525 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996

Conditions
B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • TG Therapeutics Investigational Trial Site Heidelberg, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Melbourne, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Nedlands, Western Australia, Australia
View Trial Details
Completed

Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas

NCT02341014

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT04052997

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Health - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 73 locations
View Trial Details
Completed

Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT

NCT02962167

Conditions
Atypical Teratoid/Rhabdoid Tumor, Disease Attributes, Glioma, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details

Related conditions